Browse the full management transaction log of ZyVersa Therapeutics, Inc., a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.4m. The latest transaction was disclosed on 20 December 2022 (Attribution). Among the most active insiders: Wolfe Peter. Every trade is free.
6
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
27Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.